1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
65.75%
Net income growth under 50% of CRON.TO's 499.96%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-3.39%
Both reduce yoy D&A, with CRON.TO at -29.21%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-808.97%
Negative yoy deferred tax while CRON.TO stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-10.01%
Both cut yoy SBC, with CRON.TO at -3.32%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
193.51%
Well above CRON.TO's 56.61% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-1178.75%
AR is negative yoy while CRON.TO is 202.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
18.16%
Some inventory rise while CRON.TO is negative at -96.29%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
552.49%
AP growth well above CRON.TO's 135.78%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
559.90%
Some yoy usage while CRON.TO is negative at -51.58%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
60.13%
Some yoy increase while CRON.TO is negative at -770.28%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
293.60%
Some CFO growth while CRON.TO is negative at -33.35%. John Neff would note a short-term liquidity lead over the competitor.
2.92%
Lower CapEx growth vs. CRON.TO's 44.77%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
10316.78%
Acquisition growth of 10316.78% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
200.00%
Purchases growth of 200.00% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
16.81%
We have some liquidation growth while CRON.TO is negative at -380.07%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
265.10%
We have some outflow growth while CRON.TO is negative at -102.38%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
51.11%
We have mild expansions while CRON.TO is negative at -515.16%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
94.19%
Debt repayment growth of 94.19% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.